GlucoTrack, Inc. GCTK

Company Overview

GlucoTrack, Inc. (Nasdaq: GCTK) is a medical device and digital health company focused on diabetes management technologies, primarily the development of implantable and continuous glucose monitoring (CGM) systems for people with diabetes. The company operates within the broader healthcare technology, medical device, and diabetes care industries. Its primary strategic focus is the development of long-term implantable glucose monitoring technology intended to improve glucose measurement accuracy and reduce the burden associated with traditional fingerstick testing and short-duration wearable CGM devices.

Historically, GlucoTrack was known for developing a non-invasive glucose monitoring device that used ultrasonic, electromagnetic, and thermal technologies to estimate blood glucose levels. In recent years, the company shifted its strategy toward implantable continuous glucose monitoring systems designed for extended use. The company’s revenue base has historically been limited because most resources have been directed toward research, development, regulatory preparation, and commercialization planning rather than large-scale product sales. GlucoTrack’s positioning is centered on pursuing a minimally invasive, long-duration monitoring platform intended to differentiate itself from conventional wearable CGM competitors.